- Home
- VCEL vs VISN Comparison
VCEL vs VISN Comparison
Compare VCEL & VISN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | VISN |
|---|---|---|
| Founded | 1989 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | 1996 | 2013 |
Fundamental Metrics
Financial Performance| Metric | VCEL | VISN |
|---|---|---|
| Price | $44.74 | $11.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $57.75 | $21.00 |
| AVG Volume (30 Days) | 463.2K | ★ 6.9M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 60.00 | ★ 641.01 |
| EPS | N/A | ★ 24.79 |
| Revenue | $276,259,000.00 | ★ $1,931,600,000.00 |
| Revenue This Year | $19.40 | $9.44 |
| Revenue Next Year | $18.24 | $5.91 |
| P/E Ratio | ★ N/A | $5.37 |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $9.47 |
| 52 Week High | $49.32 | $19.91 |
Technical Indicators
Market Signals| Indicator | VCEL | VISN |
|---|---|---|
| Relative Strength Index (RSI) | 48.74 | 46.28 |
| Support Level | $44.26 | $11.44 |
| Resistance Level | $49.04 | $12.80 |
| Average True Range (ATR) | 1.47 | 0.46 |
| MACD | -0.46 | -0.05 |
| Stochastic Oscillator | 25.77 | 58.82 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About VISN Vistance Networks Inc. Common Stock
Vistance Networks Inc operates in the communications technology sector, providing solutions designed to support the delivery and management of communications services. It serves customers globally through teams involved in product development, implementation, and customer support. The company designs and develops network infrastructure and connectivity solutions focused on reliability and performance. Its offerings include intelligent networking technologies intended to support evolving communication requirements.